Related Experiment Videos
Comparative value of Dapsone "spot test" and Dapsone "tile test" in leprosy control programme.
Summary
Qualitative urine screening tests for dapsone, including the "spot test" and "tile test," show high correlation with quantitative Dapsone/creatinine ratio, making them reliable for leprosy patient monitoring.
Area of Science:
- Pharmacology and Therapeutics
- Clinical Chemistry
- Public Health
Background:
- Accurate monitoring of dapsone adherence is crucial for effective leprosy treatment.
- Existing methods for assessing drug consumption can be resource-intensive.
- Qualitative field tests offer a potential alternative for widespread screening.
Purpose of the Study:
- To compare the diagnostic accuracy of two qualitative dapsone urine screening tests (spot test and tile test) against a quantitative method (Dapsone/creatinine ratio).
- To evaluate the concordance of results obtained by field-based paramedical workers and laboratory personnel.
- To assess the feasibility of implementing these tests for large-scale monitoring of leprosy patients.
Main Methods:
- 316 urine samples were analyzed using the Dapsone 'spot test' and 'tile test' in the field and laboratory.
- Samples were also subjected to quantitative Dapsone/creatinine ratio analysis in the laboratory.
- Results from qualitative tests were compared with the quantitative test and between different personnel.
Main Results:
- The qualitative spot and tile tests demonstrated a 91% correlation with the quantitative Dapsone/creatinine ratio.
- High concordance (97%) was observed between results from paramedical workers and laboratory technicians.
- Previous studies indicate such monitoring can reduce irregular drug consumption from 36% to 17%.
Conclusions:
- The dapsone spot and tile tests are reliable, simple, and portable qualitative methods for screening dapsone in urine.
- These tests can be effectively performed by paramedical workers in field settings, showing high agreement with laboratory results.
- Routine, frequent, and surprise urine testing using these field-deployable kits is recommended for mass-scale monitoring of dapsone adherence in leprosy patients.